Classifications

• • B—PERFORMING OPERATIONS; TRANSPORTING
  • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
  • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
  • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
  • B01J13/02—Making microcapsules or microballoons
  • B01J13/04—Making microcapsules or microballoons by physical processes, e.g. drying, spraying
• • B—PERFORMING OPERATIONS; TRANSPORTING
  • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
  • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
  • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
  • B01J13/02—Making microcapsules or microballoons
  • B01J13/20—After-treatment of capsule walls, e.g. hardening
• • B—PERFORMING OPERATIONS; TRANSPORTING
  • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
  • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
  • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
  • B01J13/02—Making microcapsules or microballoons
  • B01J13/20—After-treatment of capsule walls, e.g. hardening
  • B01J13/206—Hardening; drying
• • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
  • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
  • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
  • Y10T428/00—Stock material or miscellaneous articles
  • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
  • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
  • Y10T428/2984—Microcapsule with fluid core [includes liposome]
• • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
  • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
  • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
  • Y10T428/00—Stock material or miscellaneous articles
  • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
  • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
  • Y10T428/2984—Microcapsule with fluid core [includes liposome]
  • Y10T428/2985—Solid-walled microcapsule from synthetic polymer
• • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
  • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
  • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
  • Y10T428/00—Stock material or miscellaneous articles
  • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
  • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
  • Y10T428/2984—Microcapsule with fluid core [includes liposome]
  • Y10T428/2985—Solid-walled microcapsule from synthetic polymer
  • Y10T428/2987—Addition polymer from unsaturated monomers only
• • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
  • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
  • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
  • Y10T428/00—Stock material or miscellaneous articles
  • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
  • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
  • Y10T428/2989—Microcapsule with solid core [includes liposome]

Definitions

• This patent application relates to encapsulated active materials, and preferably relates to encapsulated catalysts, accelerators and curing agents.
• formulations which are useful as an adhesive, sealant, coating or in composite applications such as those based on a polysiloxane, epoxy resin, polyurethane, vinyl ester resin, polyester resin, allylic resin, polysulfide resin, phenolic resin, amino resin require contact with a catalytic species, accelerators or curing agent in order to achieve final cure.
• This cure can begin at, or slightly above, room temperature upon immediate contact between the catalytic species, accelerator or curing agent and the curable composition. Therefore, it is necessary to keep the catalytic species, accelerator or curing agent and the curable composition from coming into contact with one another until cure is desired.
• One commonly used approach is to formulate two part compositions in which the catalytic species, accelerator or curing agent is in one part and the curable composition is in another part.
• Two part compositions require shipment of two separate portions, and may require additional capital for separate containment of the catalyst, accelerator or curing agent and the curable material along with mixing equipment to mix the materials. Separate shipment and complicated equipment, such as metering and dispensing equipment, significantly adds to the cost of such a system.
• Hoffman et al. US 5,601 ,761 discloses a method of encapsulating an active material in a coating material immiscible therewith and having a melting point or transition point above ambient temperature. The method comprises, dispersing the active material in the coating material at a temperature sufficient to melt the coating material; forming droplets of active material interspersed with the coating material; cooling the droplets to solidify the coating material to form particles; and contacting the particles with a solvent that dissolves the active material but does not dissolve the coating material, so as to remove active material from the surface of the particles.
• Stewart et al. US Patent 5,120,349, assigned to Landec Polymers, discloses a process for encapsulating an active species, such as a herbicide, insecticide, fungicide, or fertilizer, in side chain crystallizable acrylate based polymers. These encapsulated active species are prepared by dissolving or dispersing the active species in a hot side chain crystallizable acrylate polymer, cooling the mixture and crystallizing the mixture. The particles formed are then ground.
• an active species such as a herbicide, insecticide, fungicide, or fertilizer
• Bitler, et al WO 96/27641 discloses the preparation of modifying agents wherein the modifying agents comprise an active chemical moiety, such as a catalyst or a curing agent, and a crystalline polymeric moiety wherein the active chemical moiety is chemically bound to the crystalline polymeric moiety. These are prepared as disclosed in Stewart. It is disclosed that these particles can be added to modify curable systems. They modify the curable systems when exposed to heat sufficient to melt the crystalline polymeric moiety and thereby bring the active chemical moiety into contact with the curable system. This system exhibits good stability but the reactivity of this system is too slow for some applications.
• Bitler et al, WO 98/1 1 166 discloses modifying agents for curable systems, which comprise crystalline polymers containing an active chemical ingredient, which is physically bound but not chemically bound to the polymeric ingredient.
• the active chemical moiety and the system are similar to those disclosed in WO 96/27641 .
• Landec markets a product under the name Intelimer® 5012 which is dibutyltin dilaurate encapsulated by a side chain crystallizable acrylate.
• the active species are partly located at the surface of the particle and/or are extractable from the particles. In some applications the presence of the active species at the surface of the particle or the extractability of the active material from the particles results in instability of some of the formulations containing the encapsulated active species. In curable formulations this instability is exhibited by premature curing of the curable composition. This is indicated by a growth in viscosity of the composition.
• the system is stable at ambient temperatures, that is , does not undergo significant viscosity growth indicative of curing, and which cures rapidly once the system is exposed to conditions so as to release the encapsulated active agent, such as the melting temperature of the encapsulating agent.
• the invention is an encapsulated active agent in particle form comprising an active agent encapsulated in a crystallizable or thermoplastic polymer wherein the particle size of the encapsulated active agent is 3,000 microns or less wherein the active agent is not significantly extractable from the particles under ambient conditions during the first extraction after particle preparation.
• the encapsulated particle has a shell layer at and near the surface which functions to prevent release of, or extraction of, the active agent at ambient temperatures.
• the shell layer contains substantially no active agent or such a low level of active agent that the stability of any formulation to which it is added is not detrimentally affected.
• the particles of the invention have a shell layer at and near the particle surface and an inner portion of the particle surrounded by the shell layer wherein the shell layer has a different crystal structure than the crystal structure of the inner portion such that the active agent is not substantially extractable from the particles under ambient conditions during the first extraction after particle formation.
• the encapsulating agent is a crystallizable polymer, and is more preferably a side chain crystallizable polymer which comprises a polymer or copolymer of an alkyl acrylate or alkyl methacrylate wherein the polymer has substituted or unsubstituted side chains of 6 to 50 carbon atoms.
• the thermoplastic or crystallizable polymer has a transition point of 40°C to 250°C.
• the active agent is not chemically bound to the encapsulating agent.
• the invention is a process for preparing an encapsulated agent which comprises a) contacting an active agent with a crystallizable or thermoplastic polymer wherein the polymer is molten and the active agent in not volatile or exhibits low volatility under the contacting conditions; b) forming particles of 3000 microns or less; c) and exposing the particles to conditions such that the portion of the particle at and near the surface undergoes rapid solidification.
• the invention is a process for preparing an encapsulated active agent which comprises heating a crystallizable or thermoplastic polymer under conditions such that the polymer is molten; contacting an active agent with the molten polymer to disperse or dissolve the active agent within the polymer; pouring the active agent dispersed or dissolved in the polymer on a rotating disk such that particles of the active agent in the polymer are formed, spun from the disk and
• the invention is the product prepared by the process described in this paragraph.
• the active agent is an encapsulated organometallic catalyst.
• the encapsulated active agents of the invention do not require washing or extraction in order for them to be stable in curable compositions. These encapsulated active agents can be designed to release the active agent at a desired temperature.
• the encapsulated agents of the invention demonstrate excellent stability at ambient temperatures and exhibit relatively rapid reactivity upon release of the active agent. Furthermore, the presence of the encapsulating agent does not result in deterioration of adhesive or elastomer properties of a cured composition after preparation.
• the active agent can be any material which is reactive in an environment and which needs to be separated from the environment until it is desired that the active agent react in the environment.
• active agents included catalysts, accelerators, curing agents, biologically active compounds, such as drugs, herbicides, fertilizers or pesticides,.
• the active agent is a catalyst, a curing agent, an accelerator, or a mixture thereof.
• the active agent may be any material that dissolves in or forms a heterogeneous slurry with the encapsulating material at temperatures at which the encapsulating agent is in the liquid form, that is molten.
• the active agent is soluble in the encapsulating material.
• the active agent may either be a liquid or a solid at room temperature but it is preferably a liquid at processing temperatures.
• the melting point of the active agent may be greater than, less than, or equal to the melting point of the encapsulating material.
• the active agent is an organometallic or organic catalyst, curing agent or accelerator which does not volatilize or degrade under the temperatures of encapsulation process.
• the active agent is a silanol condensation catalyst; a hydrosilylation catalyst; a catalyst, curing agent, or accelerator useful in preparing prepolymers or thermoset resins such as, polyurethane prepolymers or polyurethane compositions, epoxy resins, vinyl ester resins, polyester resins, allylic resins, polysulfide resins, phenolic resins, amino resins.
• the active agent is an organometallic catalyst which does not volatilize or degrade under the conditions of encapsulation.
• Catalysts useful in polyurethane reactions include tin carboxylates, organo silicon titanates, alkyl titanates, tertiary amines, tin mercaptides, napthenates or alkanoate salts of lead, cobalt, manganese, bismuth or iron.
• Urethane formation catalysts useful are well known to those skilled in the art and many examples may be found for example, in the POLYURETHANE HANDBOOK, Chapter 3, ⁇ 3.4.1 on pages 90-95; and in POLYURETHANE CHEMISTRY AND TECHNOLOGY, in Chapter IV, pages 129-217.
• Preferred tin compounds include tin(ll) salts of organic carboxylic acids, such as tin(ll) diacetate, tin(ll) dioctanoate, tin(ll) diethylhexanoate and tin(ll) dilaurate; dialkyltin(IV) salts of organic carboxylic acids, such as dibutyltin diacetate, dibutyltin dilaurate, dibutyltin maleate and dioctyltin diacetate; and stannous salts of carboxylic acids, such as stannous octoate, stannous oleate, stannous acetate, and stannous laurate.
• organic carboxylic acids such as tin(ll) diacetate, tin(ll) dioctanoate, tin(ll) diethylhexanoate and tin(ll) dilaurate
• catalysts useful in promoting the curing of polyurethanes include dimorpholinodialkyl ethers, N- alkylbenzylamines, N-alkylmorpholines, N-alkyl aliphatic polyamines, N-alkylpiperazines, triethylenediamine, amidines, such as 2,3-dimethyl-3,4,5,6-tetrahydropyrimidine, tertiary amines, such as triethylamine tributylamine, dimethylbenzylamine, N-methyl-, N-ethyl-, N- cyclohexlmorpholine, N,N,N'N,N'-tetramethylethylenediamine, N,N,N',N'- tetramethylbutanediamine, N,N,N',N'-tetramethyl-1 ,6-hexanediamine, pentamethyldiethylenetriamine, tetramethyldiaminoethyl ether, bis(dimethyl
• Active agents useful in this invention include silanol condensation catalysts, which promote the reaction of the reactive silicon groups.
• silanol condensation catalysts were titanic acid esters, such as tetrabutyl titanate, tetrapropyl titanate, etc.; organotin compounds, such as dibutyltin dilaurate, dibutyltin maleate, dibutyltin diacetate, tin octylate, tin naphthenate, dialkyi tin oxides, reaction products of dialkyltin oxide and phthalic acid esters or alkane diones, dialkyltin bis(acetylacetonate) (also commonly referred to as dialkyi tin acetylacetonates); organoaluminum compounds, such as aluminum trisacetylacetate, aluminum trisethylacetate, diisopropoxyaluminum ethyl acetate, etc.; reaction products of bismuth salts and organic carb
• silanol catalysts may be used individually or in combinations of 2 or more.
• organometallic compounds or combinations of organometallic compounds and amine compounds are preferable from the point of view of curability.
• Preferred silanol condensation catalysts are organometallic compounds.
• organotin compounds such as dibutyl tin oxide, dibutyltin dilaurate, dibutyltin maleate, dibutyltin diacetate, tin octylate, tin naphthenate, reaction products of dibutyltin oxide and phthalic acid esters, dibutyl tin bis(acetylacetonate),.
• the active agent may be a curing accelerator for an epoxy resin composition.
• Such accelerator is preferably an urea or an imidazole.
• Preferred ureas include, 3-phenyl-1 ,1 -dimethylurea; 3-(4-chlorophenyl)-1 ,1 -dimethylurea; 3-(3,4- dichlorophenyl)-1 ,1 -dimethylurea; 1 ,1 '-(4-methyl-m-phenylene)bis(3,3'-dimethylurea); 3- isomethyldimethylurea-3,5,5-trimethylcyclohexyldimethylurea; or 4,4'- methylenebis(phenyldimethylurea).
• urea is 3-phenyl-1 ,1 -dimethylurea (PDMU).
• Preferred imidazoles include alkyl- or arylimidazoles, such as 2-methylimidazoie, 2-undecylimidazole, 2-heptadecylimidazole, 2-phenylimidazole, 2-ethyiimidazole, 2- isopropylimidazole and 2-phenyl-4-methylimidazole; 1 -cyanethyl derivatives, such as 1 - cyanoethyl-2-methylimidazole, 1 -cyanoethyl-2-phenylimidazole, 1 -cyanoethyl-2- undecylimidazole, and 1 -cyanoethyl-2-isopropylimidazole; and carboxylic salts, such as 1 - cyanoethyl-2-ethyl-4-methylimidazole-trimellitate.
• the active agent may be a hydrosilylation catalyst.
• hydrosilylation catalysts are described in US Patent 5,567,833 at Column 17, lines 26 to 54; US Patent 5,409, 995; US Patent 3,971 ,751 ; and US 5,223,597.
• the most preferred hydrosilylation catalyst is chloroplatinic acid.
• the active agent can be an amine or an imidazole which functions as a catalyst, curing agent or accellerator in a polymeric curing reaction. Included in the useful amines are primary, secondary and tertiary amines as described herein.
• the active agent is a free radical catalyst or initiator.
• Free radical catalysts and initiators are well known in the art, examples were disclosed in US Patent 4,618,653; and ' US Patent 5,063,269 at column 6, lines 37 to 54.
• the active agent is an organometallic compound, more preferably the active agent is an organotin compound.
• the organotin compounds useful are dialkyltin oxides such as dibutyltin oxide, dialkyltin bis(acetylacetonate), or the reaction product of dibutyltin oxide in a phthalic ester or pentanedione.
• the active agent is an organic based active agent
• care must be taken to make sure that the organic active agent and encapsulating agent are chosen such that the organic active agent can be encapsulated within the encapsulating agent at a temperature at which the organic active agent does not volatilize.
• the use of an encapsulating agent that the active agent is soluble in reduces the volatility of the active agent and enhances the formation of the desired particles. Does not volatilize herein means that under the conditions of the encapsulated active agent particle formation the formed particle does not exhibit substantial extraction of the active agent at ambient conditions during the first extraction after particle formation.
• the active agent has a low partial pressure under particle formation conditions. Active agents exhibit enhanced solubility in encapsulating agents having a polar nature, such as, for example, polyester, polyamides, and side chain crystalline polymers.
• the encapsulating agent is a thermoplastic or crystallizable polymer, which has a transition point from 40°C to 250°C.
• Transition point refers to the point at which the thermoplastic or crystallizable polymer undergoes a change, which results in the release of the active agent.
• One transition point is where the thermoplastic or crystallizable polymer melts and releases the active agent.
• Another transition point is where the thermoplastic or crystallizable polymer changes sufficiently to allow the active agent to permeate out of the particles. It is preferable that the thermoplastic or crystallizable polymeric moiety should cross over the transition point, for instance melt, over a relatively small temperature range so that release of the active agent can occur quickly.
• the thermoplastic or crystallizable polymer has a transition point at a temperature of 40°C or greater, more preferably 50°C or greater and most preferably 60°C or greater.
• such thermoplastic or crystallizable polymer has a transition point at 250°C or less more preferably 200°C or less and most preferably 1 10°C or less.
• the encapsulating agent is a crystalline polymer.
• thermoplastic polymers include styrenics, styrene acrylonitriles, low molecular weight chlorinated polyethylenes, soluble cellulosics, acrylics, such as those based on methyl methacrylate or cycloaliphatic acrylates.
• the crystalline polymer is a polyolefin, polyester, polyamide, phenoxy thermoplastic, polylactic acid, polyether, polyalkylene glycol or a side chain crystallizable polymer. More preferably the crystallizable polymer is a polyethylene, polypropylene, polyether, polyethylene glycol, phenoxy thermoplastic, polylactic acid or side chain crystallizable polymer. Even more preferably the crystallizable polymers are polyethylene, polyethylene glycol or a side chain crystallizable polymer, with side chain acrylate polymers being most preferred.
• the crystallizable polymer can be derived from a single polymer or from a mixture of polymers, and the polymer can be a homopolymer, or a copolymer of two or more comonomers, including random copolymers, graft copolymers, block copolymers and thermoplastic elastomers.
• at least part of the crystallizable polymer is derived from a side chain crystallizable (SCC) polymer.
• SCC polymer may for example be derived from one or more acrylic, methacrylic, olefinic, epoxy, vinyl, ester-containing amide- containing or ether-containing monomers. The preferred SCC polymeric moieties are described in detail below.
• the invention includes other crystalline polymers having the desired properties.
• SCC polymer moieties which can be used in this invention include moieties derived from known SCC polymers, for example polymers derived from one or more monomers such as substituted and unsubstituted acrylates, methacrylates, fluoroacrylates, vinyl esters, acrylamides, methacrylamides, maleimides, ⁇ -olefins, p-alkyl styrenes, alkylvinyl ethers, alkylethylene oxides, alkyl phosphazenes and amino acids; polyisocyanates; polyurethanes; polysilanes; polysiloxanes; and polyethers; all of such polymers contain long chain crystallizable groups.
• Suitable SCC polymers are described for example in J. Poly. Sci. 60,19 (1962), J. Poly. Sci. (Polymer Chemistry) 7, 3053 (1969), 9, 1835, 3349, 3351 , 3367, 10, 1657, 3347, 18, 2197, 19,1871 , J. Poly. Sci. Polymer Physics Ed. 18,. 2197 (1980), J. Poly. Sci. Macromol. Rev. 8, 1 17 (1974), Macromolecules 12, 94 (1979), 13, 12, 15, IS, 2141 , 19, 61 1 , JACS Z5,3326 (1953), 76; 6280, Polymer J. 17, 991 (1985); and Poly. Sci. USSR 21, 241 (1979).
• SCC polymer moieties which are preferably used in this invention, can be broadly defined as moieties which comprise repeating units of the general formula: -Y-
• Y is an organic radical forming part of the polymer backbone and Cy comprises a crystallizable moiety.
• the crystallizable moiety may be connected to the polymer backbone directly or through a divalent organic or inorganic radical, for example an ester, carbonyl, amide, hydrocarbon (for example phenylene), amino, or ether link, or through an ionic salt linkage (for example a carboxyalkyl ammonium, sulfonium or phosphonium ion pair).
• the radical Cy may be aliphatic or aromatic, for example alkyl of at least 10 carbons, fluoralkyl of at least 6 carbons or p-alkyl styrene wherein the alkyl contains 6 to 24 carbons.
• the SCC moiety may contain two or more different repeating units of this general formula.
• the SCC may also contain other repeating units, but the amount of such other units is preferably such that the total weight of the crystallizable groups is at least equal to, for example twice, the weight of the remainder of the block.
• Preferred SCC moieties comprise side chains containing in total at least 5 times as many carbon atoms as the backbone of the moiety, particularly side chains comprising linear polymethylene moieties containing 12 to 50, especially 14 to 22 carbon atoms, or linear perfluorinated or substantially perfluorinated polymethylene moieties containing 6 to 50 carbon atoms.
• Polymers containing such side chains can be prepared by polymerizing one or more corresponding linear aliphatic acrylates or methacrylates, or
• monomers such as acrylamides or methacrylamides.
• a number of such monomers are available commercially, either as individual monomers or as mixtures of ' identified monomers, for example C12A, C14A, C16A, C18A, C22A, a mixture of C18A, C20A and C22A, a mixture of C26A to C40A, fluorinated C8A (AE800 from American Hoechst) and a mixture of fluorinated C8A, C1 OA and C12A (AE12 from American
• the polymers can optionally also contain units derived from one or more other comonomers preferably selected from other alkyl, hydroxyalkyl and alkoxyalkyl acrylates, methacrylates (for example glycidal methacrylates); acrylamides and methacrylamides, acrylic and methacrylic acids; acrylamide; methacrylamide; maleic anhydride; and comonomers containing amide groups.
• Such other co-monomers are generally present in total amount less than 50 percent particularly less than 35 percent especially less than 25 percent, for example 0 to 15 percent. They may be added to modify the transition point or other physical properties of the polymers.
• the transition point of a polymer containing such polymethylene side chains is influenced by the number of carbon atoms in the crystallizable side chains.
• homopolymers of C14A, C16A, C18A, C20A, C22A, C30A, C40A and C50A respectively typically have melting points of 20, 36, 49, 60, 71 , 76, 96 and 102°C, while the homopolymers of the corresponding n-alkyl methacrylates typically have melting points of 10, 26, 39, 50, 62, 68, 91 and 95°C.
• Copolymers of such monomers generally have intermediate melting points.
• Copolymers with other monomers, for example acrylic acid or butyl acrylate typically have somewhat lower melting points.
• polymers which can provide SCC moieties for use in this invention include atactic and isotactic polymers of n-alkyl ⁇ -oiefins (for example the atactic and isotactic polymers of C 16 olefin, having T m 's of 30°C and 60°C respectively); polymers of n- alkylglycidyl ethers (for example the polymer of C 18 alkyl glycidylether); polymers of n-alkyl vinyl ethers (for example the polymer of C 18 alkylvinylether having a T m of 55°C; polymers of n-alkyl- ⁇ -epoxide having a T m of 60°C); polymers of n-alkyl oxycarbonylamido- ethylmethacrylates (for example the polymers of C 18 IEMA, C 22 IEMA and C 30 IEMA having T m 's of 56°C, 75°C and 79°C respectively
• hydroxyalkyl acrylate or methacrylate a hydroxyalkyl acrylate or methacrylate, and a primary fatty, alcohol (for example the polymers obtained by reacting hexamethylene diisocyanate, 2-hydroxyethyl acrylate, and C 18 or C 22 alcohols, and having T m 's of 103°C and 106°C respectively).
• a primary fatty, alcohol for example the polymers obtained by reacting hexamethylene diisocyanate, 2-hydroxyethyl acrylate, and C 18 or C 22 alcohols, and having T m 's of 103°C and 106°C respectively.
• Preferred SCC polymer moieties used in this invention comprise 30 to 100 percent preferably 40 to 100 percent, of units derived from at least one monomer selected from the group consisting of alkyl acrylates, alkyl methacrylates, N-alkyl acrylamides, N-alkyl methacrylamides, alkyl oxazolines, alkyl vinyl ethers, alkyl vinyl esters, ⁇ -olefins, alkyl 1 ,2- epoxides and alkyl glycidyl ethers in which the alkyl groups are n-alkyl groups containing 12 to 50 carbon atoms, and the corresponding fluoroalkyl monomers in which the thermoalkyl groups are n-fluoroalkyl groups containing 6 to 50 carbon atoms; 0 to 20 percent of units derived from at least one monomer selected from the group consisting of alkyl acrylates, alkyl methacrylates, N-alkyl acrylamides, alkyl vinyl
• Such SCC moieties may also contain units derived from other monomers to change compatibility with the matrix, or to raise the modulus of a reaction product containing the modifying agent; such monomers include styrene, vinyl acetate, mono acrylic functional polystyrene.
• the side chain crystalline polymers used do not contain a significant amount of functional groups, such as those having active hydrogen atoms, as the presence of a significant amount of active hydrogen atoms increases the viscosity of the polymers and this can negatively impact the process used to prepare the encapsulated active agent particles.
• the number average molecular weight of the SCC polymer moiety is preferably less than 200,000, more preferably less than 100,000, particularly less than 50,000, more particularly 1 ,000 to 20,000.
• the molecular weight of the SCC polymer moiety can be adjusted (for example through choice of the reaction conditions and addition of chain transfer agents) so as to optimize the reactivity of attached moieties without substantial change in Tm.
• the encapsulated active agent may be prepared by the following procedures: a) dispersing or dissolving the active agent in the encapsulating material at a temperature sufficient to melt the encapsulating material and not so high that the active agent volatilizes; b) forming droplets of active agent interspersed with the encapsulating material; and c)
• the process may further comprise d) contacting the droplets with a solvent that dissolves the active agent but does not dissolve the encapsulating material, so as to remove active agent from the surface of the encapsulating material. It is preferable to avoid this last step.
• a solvent that dissolves the active agent but does not dissolve the encapsulating material, so as to remove active agent from the surface of the encapsulating material. It is preferable to avoid this last step.
• This process is described in US Patent 5,601 ,761 . More particularly the encapsulating agent is heated until it is in the liquid state, that is molten. Thereafter, the active agent is dispersed in the encapsulating agent. Preferably, the active agent is not volatile under the conditions at which the encapsulating agent is molten.
• the mixture is formed into particles, preferably of 3000 microns or less.
• Rapidly solidify means that the active agent in the particles formed are not substantially extractable from the particles formed at ambient conditions in a first extraction after particle formation. Further evidence of rapid solidification is the formation of a shell the particle wherein the encapsulating agent has a different crystal structure than the interior portion of the particle.
• rapid solidification means the particles solidify at the surface in a matter of seconds, preferably 10 seconds or less and more preferably 5 seconds or less.
• exposing the particles to rapid quenching results in the desired structure and properties of the particles.
• Any means of allowing the particles to rapidly solidify at the surface may be used. Passing the particles through a zone of air or an inert gas at ambient temperatures or a cooled zone is one method of rapidly solidifying the surface of the particles. Any process which disperses particles of the molten formulation it on a cooling zone, such as an air zone, may be used.
• the temperature of the process is selected such that the encapsulating agent is in a molten or liquid form and has a suitable viscosity for the processing technique used, such as rotating disk. Further the temperature and other process conditions should be chosen such that the active agent is not volatile. Generally not volatile or low volatility as used herein means the active agent has a low partial pressure. One skilled in the art can readily determine appropriate conditions and components and acceptable volatility levels. In general preferred temperatures at which the active agent is contacted with the encapsulating material is 40°C or greater, more preferably 100°C or greater, most preferably 120°C or greater and preferably 250°C or less, more preferably 200°C or less and most preferably 180°C or less.
• a preferred process for preparation of the particles is a rotating disk process.
• the mixture prepared have a viscosity, which is suitable for use with the rotating disk.
• the viscosity of the material is 500 centipoise or less, more preferably 100 centipoise or less and most preferably 50 centipoise or less.
• the active agent dissolves in the molten polymer.
• the active agent is preferably mixed with a encapsulating agent in the molten state at a temperature at which the active agent or a mixture thereof is not volatile. Under these circumstances, the particle prepared will not exhibit significant extraction of the active agent at ambient temperatures. This results in a very stable encapsulated active agent and a very stable adhesive formulation prepared from such active agent.
• the temperature of the molten mixture which is poured on the disk is 75°C or greater, more preferably 100°C or greater and most preferably 120°C or greater and is preferably 250°C or less, more preferably 200°C or less and most preferably 180°C or less.
• the disk is rotating at 500 rpm or greater, more preferably 1 ,000 rpm or greater and most preferably 5,000 rpm or greater. The upper limit on the disk rotation speed is practicality.
• the encapsulated active agent preferably exhibits a shell of crystalline polymer a mixture of polymer having dispersed therein an active agent.
• the crystal structure of this shell layer is different than the crystal structure of the encapsulating agent crystal structure at the interior of the particle.
• the ability of the particle to resist extraction of the active agent using a solvent is an indication that the encapsulated active agent will be stable in a formulation at ambient temperatures, meaning significant amounts of the active agent will not come into contact with the curable composition and initiate cure at ambient temperatures, in one preferred embodiment it is believed that the encapsulated active agent of the invention preferably has a shell of crystalline polymer which has a crystal structure which is somewhat different than the structure of the polymer on the interior of the
• the active agent is not significantly extractable from the particles of active agent in encapsulating agent.
• not substantially extractable is meant that there is no need to wash the surface of the particle with a solvent to make the particle stable in the adhesive formulation.
• not substantially extractable means 10 percent or less of the active agent based on the amount of active agent in the encapsulated active agent is extracted by a solvent or plasticizer when the particles are contacted with the solvent or plasticizer for the active agent, more preferably 5 percent or less, even more preferably 1 percent or less, even more preferably 0.5 percent by weight or less and most preferably 0.1 percent by weight or less.
• the amount of active agent extracted is below the detection limits of the analytical techniques used to measure for the active agent as demonstrated in Example 36 herein.
• the active agent upon release can rapidly activate or initiate reaction or cure.
• the particles have a particle size of 3000 microns or less, more preferably 300 microns or less even more preferably 150 microns or less, and most preferably 70 microns or less.
• the particles have a particle size of 10 microns or more, more preferably 30 microns or more and even more preferably 50 microns or more. It is believed that a narrow particle size distribution enhances the performance of the particles of the invention in the intended uses.
• the particles demonstrate a narrow particle size distribution.
• Particle size as used herein can be measured by laser scattering particle size analysis as disclosed in Example 36.
• the particles have a low aspect ratio and even more preferably are spherical in shape.
• the concentration of active agent in the encapsulating agent particles is preferably 1 weight percent or greater, more preferably 20 weight percent or greater and most preferably 25 weight percent or greater.
• the concentration of active agent in the particles is preferably 70 weight percent or less, more preferably 65 weight percent or less, even more preferably to 50 weight percent or less, and most preferably to 45 weight percent or less based on the total weight of active agent and encapsulating material.
• the encapsulated active agents of the invention exhibit rapid activation times.
• Activation time means the time it takes for the curing reaction to start as exhibited by the onset of gellation. This time is measured from the time the composition is exposed to a means of causing the encapsulating agent to release the active agent, such as a heat source, to the time at which noticeable gellation occurs.
• the encapsulated active agents exhibit activation times which approach the activation times of unencapsulated active
• the encapsulation of the active agent does not significantly slow the activation of the curable composition.
• the formulation containing the ' encapsulated active agent begins cure after exposure to activation conditions for 10 minutes or less and more preferably 5 minutes or less and most preferably 5 minutes or less.
• the encapsulated active agents of the invention can be used in any environment where there is the need for a controlled release of the active material.
• the encapsulated agent can be mixed into a formulation of the reactive components and other adjuvants.
• To activate the reaction the formulation is exposed to conditions, which release the active agent.
• Such conditions may be exposure to the necessary temperature at which the encapsulating material melts or which the active agent is able to permeate through the encapsulating agent.
• the conditions could be shear or exposure to ultrasonic waves, which cause the encapsulating material to release the active material.
• the encapsulated active agents of the invention can be used in adhesive and coating formulations.
• the encapsulated active agents of the invention demonstrate excellent stability in curable formulations.
• Formulations containing the encapsulated active agents preferably demonstrate stability for greater than 3 days when exposed to ambient conditions (23°C and 50 percent relative humidity) and even more preferably for 5 days or greater.
• Stability means that the composition is not fully cured and preferably means the composition has not undergone significant cross-linking as evidenced by viscosity growth.
• a C 22 polyacrylate homopolymer (available from Landec Corporation Menlo Park California), (800g) was heated to molten (m.p.>70°C) and Neostann® U-220 dibutyltin bis(acetyl acetonate) (200g) was added.
• the tin catalyst was soluble in the molten polymer and the solution was heated to 130°C.
• the solution of tin catalyst in polyacrylate was pumped at a rate of 132 g/min on to the surface of a rotating disk that had been heated to 125°C and was rotating at a rate of 15,000 rpm.
• the molten solution formed particles, which were spun into ambient air in a collection room over a period of 7 to 8 minutes.
• the final product was a yellow powdery solid having particle sizes ranging from 20 - 80 microns as observed under a light microscope.
• Example 2 In the same manner as described in Example 1 , a copolymer of a C 22 acrylate monomer and 1 percent acrylic acid (available from Landec Polymers Menlo Park California) lot no. 1001 1 (800g), was heated to molten (m.p.>70°C) and Neostann® U-220 dibutyltin bis(acetyl acetonate) (200g) was added. Again, the tin catalyst was soluble in the molten polymer and the solution was heated to 155°C. The solution of tin catalyst in polyacrylate was pumped at a rate of 132 g/min on to the surface of a rotating disk that had been heated to 159°C.
• the molten solution formed particles, which were spun into ambient air in a collection room over a period of 7 minutes. The particles formed settled to the floor and were collected on butcher paper. The final product was a beige powdery solid having particle sizes ranging from 20 to 80 microns as observed under a light microscope.
• the encapsulated tin catalysts were formulated into model silicone room temperature vulcanizable (RTV) formulations and evaluated for stability and reactivity.
• RTV room temperature vulcanizable
• Neostann U-220 tin catalyst (not encapsulated)
• Formulation 1 had 16-17 days storage stability without gellation. However, Comparison Formulation 1 gels within hours.
• encapsulated active agents were prepared from various encapsulating agents and catalytic materials.
• the encapsulating agent's catalytic materials are listed below.
• Table 1 is a list of the encapsulated active materials made, the loading level, particle size and process temperature. The process for preparing the particles was as described in Example 1.
• Formulation 1 was used as the basis for the testing. Samples were mixed by hand until the resin and plasticizer were homogeneous and the capsules were well dispersed. The
• 18 encapsulating agent is which is a C 22 side chain polyacrylate polymer having a weight average molecular weight of 12,000 and a number average molecular weight 7,000.
• the catalyst is dibutyl tin acetylacetonate sold under the Trademark and Designation of Neostann U-220 by Nitto Denko.
• the particles contained 80 percent by weight of encapsulating agent and 20 percent by weight of catalyst. The theoretical tin level of the encapsulated tin particles was 5.5 percent by weight.
• Example 36 the encapsulated catalyst was prepared using the process as described in Example 1.
• Comparative Example A the encapsulated catalyst was prepared using the process described in WO 98/1 1 166 see Examples 1 and 4.
• Comparative Example B a spray drying process was used to prepare the encapsulated catalyst.
• the elemental tin analysis was performed by the Neutron Activation Method. Samples and standards are irradiated in a neutron field to create radioactive isotopes of the elements of interest. These radioactive isotopes decay by the emission of gamma radiation characteristic of the activated elements. In the case of tin, two isotopes emit gamma rays with energies of 160 and 332 KeV. The half-lives of these two isotopes are 40.1 and 9.6 minutes, respectively. Following some decay period, the gamma radiation spectra from each of the samples and standards are measured using high purity germanium detectors.
• the peak areas of the gamma rays of interest are compared to those of a standard of known concentration. The ratio of the peak areas is then used to calculate the concentration of the element of interest in the sample.
• Particle sizes were determined by using a Horiba LA 910 Laser Scattering Particle Size Analyzer. Samples were prepared by dispersing the capsules in Isopar G with 0.1 percent Aerosol OT 100. Samples were sonicated to break up the agglomerates.
• Particle sizes of samples were also analyzed using a light obscuration based particle size analyzer.
• the equipment included a Climet CI-1000 signal processor and either an RLV2-100EH or RLV5-250EH sensor.
• the samples were prepared by taking approximately 0.15gram of material and placing it in a 25ml vial; 3-5ml of 1 percent Triton X-100 in isopropanol was added to the dry powder to wet the particles. The dispersion was then sonicated for approximately 30 seconds to break up any agglomerate. Approximately 20ml of water were then added to the dispersion to further dilute it. The dispersion was passed through a 250-micron (60-mesh) sieve to remove any large.
• the recipe to perform extraction studies is 10 parts by weight of capsules and 90 parts by weight of heptane.
• Capsules and heptane were added to an Erlenmeyer flask.
• the dispersion of capsules was mixed at room temperature in a capped flask equipped with a magnetic stirrer bar for 30 minutes.
• the sample was filtered on a Buchner funnel that had a disk of No. 1 Whatman filter paper, dried and analyzed for tin.
• Table 2 shows the elemental tin analysis for each of the samples.
• Table 3 tabulates the particle sizes of the capsules as determined by a light obscuration based particle size analyzer as described above.
• Comparative Experiment A air milled
• Comparative Experiment B spray dried
• Samples from Comparative Experiment B had very large particles present.
• Example 36 prepared by the rotating disk method had a narrower particle size distribution than either of the other two samples. Overall, the rotating disk sample has a much lower fraction of particles greater than 250 microns.
• the particle size of the comparative encapsulated catalysts used were also determined using a Horiba LA 910 Laser Scattering particle size analyzer by dispersing the powder in Isopar G with 0.1 Aerosol OT 100. The samples were sonicated to break up agglomerated particles. The results are compiled in Table 4.
• Table 5 shows a performance comparison in terms of both reactivity and stability of the encapsulated catalysts.
• Example 36 prepared by the rotating disk process cleariy had better stability and reactivity than either of the samples prepared by air milling (Comparative A) or spray drying (Comparative B).
• Heptane is a good solvent for Neostann U-220 tin catalyst; but, a poor solvent for the Intelimer 8065 side chain crystalline acrylate polymer at ambient temperature.
• washing capsules with heptane is expected to either remove tin catalyst remaining on the capsule surface or extract tin from the capsule interior. Based on this, a correlation is expected between these test results and the stability of the formulations. The best stability (>21 days) is obtained with the Example 36 (rotating disk) sample which also had the lowest level of lost tin.
• the results demonstrate that preparation of capsules according to Example 36 (rotating disk) was superior to the preparation according to Comparative Example A or B (air milling or spray drying methods).
• the particle size distribution was narrower with a lower fraction of particles greater than 250 microns for the Example 36 (rotating disk) sample.
• the reactivity was greater for the Example 36 (rotating disk) sample with cure being obtained on the hot plate in this series of experiments.
• the Comparative Example A (air milled) sample had reactivity approaching that for the Example 36 (rotating disk) sample.
• the Comparative Example B (spray dried) sample had much lower reactivity.
• the stability of the Example 36 sample prepared by rotating disk was better than either the Comparative Example A (air milled) or Comparative Example B (spray dried) samples.
• the Comparative Example B (spray dried) sample had stability that was superior to the Comparative Example A (air milled) sample.
• Example 36 Rotating disk
• Comparative Example A air milled
• Comparative Example B spray dried
• Example 23 used for their preparation give a tradeoff in performance between stability and reactivity. This difference correlates with particle size. That is, the larger particles prepared according to Comparative Example B (spray drying) have lower reactivity and higher stability than the particles prepared according to Comparative Example A (air milled). There is a correlation between stability and extractable tin catalyst. The very low levels of extractable tin obtained in Example 36 (rotating disk) correlate with much greater stability.
• Formulations according to Formulation 2 were prepared with the three encapsulated catalysts as described in Example 36 and Comparative Examples A and B and with unencapsulated dibutyl tin bisacetylacetonate NeostanTM U220 available from Nitto.
• Formulation 2 comprises 100 parts by weight of Kaneka S-303H methoxysilyl- terminated polypropyleneoxide based polyether, 40 parts by weight of a mixed alkyl phthalate plasticizer, PlatinolTM 71 1 P plasticizer and 3.416 part of encapsulated catalyst or 0.5 parts of unencapsulated catalyst.
• the same four catalyst systems were tested in Formulation 3.
• Formulation 3 comprises 99 parts by weight of Kaneka S-303H methoxysilyl-terminated polypropyleneoxide based polyether, 1 part by weight of water and 3 parts by weight of encapsulated catalyst or 0.6 parts by weight of unencapsulated catalyst.
• the formulations were tested according to the following procedures. The sample formulations, 7 grams, are heated on a hot plate set at 100°C for 2.5 minutes and the time until the formulation gelled was recorded. The tack free time of the samples were noted and recorded. The time until the formulation cured was noted and recorded. Seven grams of each formulation is exposed to 85°F and the time until a gel forms is recorded. The results are compiled in Table7.
• the formulations described in Table 6 were also subjected to the following tests.
• the time for the formulation to reach 50,000 centipoise was measured using a Brookfield viscometer model LVT with spindle number 4 at 25°C. For the short time periods the samples were measured continuously and for the longer times samples were spot tested.
• Ten gram samples in aluminum pans were tested for gel time at 25°C. The gel time was determined by the time at which the sample could be touched with a spatula and the spatula remained dry.
• the tack free time was the time at which the sample no longer had surface tack, dry surface feel.
• Cure time was determined at 25°C was determined to be the time to reach 90 percent of the ultimate heat cured properties as measured by a Shore A durometer. The results are compiled in Table 8.

Priority Applications (7)

Applications Claiming Priority (2)

Publications (1)

Family

ID=22176365

Family Applications (1)

Country Status (12)

Cited By (5)

Families Citing this family (50)

Citations (4)

Family Cites Families (25)

• 1999
  • 1999-04-27 US US09/300,339 patent/US6224793B1/en not_active Expired - Lifetime
  • 1999-04-27 CN CNB998055018A patent/CN1207090C/zh not_active Expired - Fee Related
  • 1999-04-27 ES ES99918850T patent/ES2212552T3/es not_active Expired - Lifetime
  • 1999-04-27 KR KR1020007011990A patent/KR100577629B1/ko not_active IP Right Cessation
  • 1999-04-27 DE DE69914739T patent/DE69914739T2/de not_active Expired - Lifetime
  • 1999-04-27 CA CA002330472A patent/CA2330472C/en not_active Expired - Fee Related
  • 1999-04-27 AT AT99918850T patent/ATE259257T1/de not_active IP Right Cessation
  • 1999-04-27 EP EP99918850A patent/EP1077763B1/en not_active Expired - Lifetime
  • 1999-04-27 AU AU36667/99A patent/AU3666799A/en not_active Abandoned
  • 1999-04-27 BR BRPI9910337-0A patent/BR9910337B1/pt not_active IP Right Cessation
  • 1999-04-27 WO PCT/US1999/009105 patent/WO1999055454A1/en active IP Right Grant
  • 1999-04-27 JP JP2000545641A patent/JP2002513045A/ja not_active Withdrawn
• 2010
  • 2010-11-25 JP JP2010262560A patent/JP5351131B2/ja not_active Expired - Fee Related

Patent Citations (4)

Also Published As

Similar Documents

Legal Events